ProShare Advisors’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $9.91K | Sell |
|
|||||
|
2024
Q4 | $54.1K | Buy |
|
|||||
|
2024
Q3 | $40.5K | Buy |
|
|||||
|
2024
Q2 | $29.8K | Sell |
|
|||||
|
2024
Q1 | $89.2K | Buy |
|
|||||
|
2023
Q4 | $42.6K | Sell |
|
|||||
|
2023
Q3 | $27.4K | Buy |
|
|||||
|
2023
Q2 | $67.3K | Buy |
|
|||||
|
2023
Q1 | $75.5K | Sell |
|
|||||
|
2022
Q4 | $118K | Buy |
|
|||||
|
2022
Q3 | $122K | Buy |
|
|||||
|
2022
Q2 | $80K | Sell |
|
|||||
|
2022
Q1 | $88K | Sell |
|
|||||
|
2021
Q4 | $161K | Buy |
|
|||||
|
2021
Q3 | $231K | Sell |
|
|||||
|
2021
Q2 | $412K | Buy |
|
|||||
|
2021
Q1 | $385K | Buy |
|
|||||
|
2020
Q4 | $595K | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $110K | Sell |
|
|||||
|
2018
Q2 | $201K | Sell |
|
|||||
|
2018
Q1 | $188K | Sell |
|
|||||
|
2017
Q4 | $214K | Buy |
|